Cervical cell gene methylation detection kit and detection method
The invention discloses a cervical cell gene methylation detection kit and a detection method, an MTHFR PCR reaction solution, a PAX1 PCR reaction solution and an SGSH PCR reaction solution provided in the kit contain specific primers and probes for detecting target genes MTHFR, PAX1 and SGSH, the d...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a cervical cell gene methylation detection kit and a detection method, an MTHFR PCR reaction solution, a PAX1 PCR reaction solution and an SGSH PCR reaction solution provided in the kit contain specific primers and probes for detecting target genes MTHFR, PAX1 and SGSH, the detection sensitivity is high, and the specificity is good. Based on a fluorescent quantitative PCR (Polymerase Chain Reaction) technology, the detection reagent disclosed by the invention is used for carrying out methylation joint detection on three target genes MTHFR, PAX1 and SGSH in a detection sample, so that whether the sample is cancerous or not is judged, differences possibly caused by site selection and a reaction system are effectively supplemented, and the accuracy of cervical cancer screening is improved.
本发明公开了一种宫颈细胞基因甲基化检测试剂盒及检测方法,试剂盒中提供的MTHFR PCR反应液、PAX1 PCR反应液、SGSH PCR反应液中含有检测目标基因MTHFR、PAX1、SGSH的特异性引物和探针,检测灵敏度高,特异性好。基于荧光定量PCR技术,使用本发明检测试剂对检测样本中三个目标基因MTHFR、PAX1、SGSH进行甲基化联合检测,据此判断样本是否癌变,有效补充了可能由于位点选择以及反 |
---|